# Giftify, Inc.: financial statements, quarterly

GIFT · Nasdaq · CIK 1760233 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gift.md) · [Financials](/companies/gift/financials.md) · [Filings](/companies/gift/filings.md) · [Insiders](/companies/gift/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gift/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.2](/filings/0001493152-24-045009.md) | [21.7 d](/filings/0001641172-25-005415.md) | [21.5](/filings/0001641172-25-009850.md) | [20.0](/filings/0001641172-25-023338.md) | [23.2](/filings/0001493152-25-021421.md) | [24.2 d](/filings/0001493152-26-016199.md) | [22.3](/filings/0001493152-26-022415.md) | [20.9](/filings/0001493152-26-035759.md) | [18.8](/filings/0001493152-25-021421.md) | [21.2 d](/filings/0001493152-26-016199.md) | [21.4](/filings/0001493152-26-022415.md) | [21.7](/filings/0001493152-26-035759.md) |
| Cost of revenue | $m | [17.6](/filings/0001493152-24-045009.md) | [18.9 d](/filings/0001641172-25-005415.md) | [18.3](/filings/0001641172-25-009850.md) | [16.8](/filings/0001641172-25-023338.md) | [20.2](/filings/0001493152-25-021421.md) | [20.5 d](/filings/0001493152-26-016199.md) | [18.7](/filings/0001493152-26-022415.md) | [17.0](/filings/0001493152-26-035759.md) | [15.0](/filings/0001493152-25-021421.md) | [16.9 d](/filings/0001493152-26-016199.md) | [17.1](/filings/0001493152-26-022415.md) | [17.3](/filings/0001493152-26-035759.md) |
| Gross profit | $m | [2.6](/filings/0001493152-24-045009.md) | [2.3 d](/filings/0001641172-25-005415.md) | [3.3](/filings/0001641172-25-009850.md) | [3.3](/filings/0001641172-25-023338.md) | [3.0](/filings/0001493152-25-021421.md) | [3.6 d](/filings/0001493152-26-016199.md) | [3.6](/filings/0001493152-26-022415.md) | [3.9](/filings/0001493152-26-035759.md) | [3.7](/filings/0001493152-25-021421.md) | [4.3 d](/filings/0001493152-26-016199.md) | [4.2](/filings/0001493152-26-022415.md) | [4.4](/filings/0001493152-26-035759.md) |
| Selling, general and administrative | $m | [2.6](/filings/0001493152-24-045009.md) | [2.9 d](/filings/0001641172-25-005415.md) | [5.2](/filings/0001641172-25-009850.md) | [9.8](/filings/0001641172-25-023338.md) | [5.9](/filings/0001493152-25-021421.md) | [6.7 d](/filings/0001493152-26-016199.md) | [6.0](/filings/0001493152-26-022415.md) | [5.7](/filings/0001493152-26-035759.md) | [5.5](/filings/0001493152-25-021421.md) | [5.7 d](/filings/0001493152-26-016199.md) | [6.2](/filings/0001493152-26-022415.md) | [5.0](/filings/0001493152-26-035759.md) |
| Operating income | $m | [(0.4)](/filings/0001493152-24-045009.md) | [(1.9) d](/filings/0001641172-25-005415.md) | [(2.9)](/filings/0001641172-25-009850.md) | [(7.5)](/filings/0001641172-25-023338.md) | [(3.8)](/filings/0001493152-25-021421.md) | [(4.2) d](/filings/0001493152-26-016199.md) | [(3.2)](/filings/0001493152-26-022415.md) | [(2.6)](/filings/0001493152-26-035759.md) | [(2.5)](/filings/0001493152-25-021421.md) | [(2.1) d](/filings/0001493152-26-016199.md) | [(2.7)](/filings/0001493152-26-022415.md) | [(1.3)](/filings/0001493152-26-035759.md) |
| Income tax | $m | [(0.0)](/filings/0001493152-24-045009.md) | [0.1 d](/filings/0001641172-25-005415.md) | not reported | not reported | not reported | not reported | [(0.2)](/filings/0001493152-26-022415.md) | [(0.1)](/filings/0001493152-26-035759.md) | [(0.1)](/filings/0001493152-25-021421.md) | not reported | [(0.1)](/filings/0001493152-26-022415.md) | [(0.1)](/filings/0001493152-26-035759.md) |
| Net income | $m | [(0.6)](/filings/0001493152-24-045009.md) | [1.5 d](/filings/0001641172-25-005415.md) | [(3.2)](/filings/0001641172-25-009850.md) | [(7.7)](/filings/0001641172-25-023338.md) | [(4.1)](/filings/0001493152-25-021421.md) | [(3.8) d](/filings/0001493152-26-016199.md) | [(3.2)](/filings/0001493152-26-022415.md) | [(2.6)](/filings/0001493152-26-035759.md) | [(2.4)](/filings/0001493152-25-021421.md) | [(2.2) d](/filings/0001493152-26-016199.md) | [(2.7)](/filings/0001493152-26-022415.md) | [(1.2)](/filings/0001493152-26-035759.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001493152-24-045009.md) | not reported | [(0.13)](/filings/0001641172-25-009850.md) | [(0.30)](/filings/0001641172-25-023338.md) | [(0.16)](/filings/0001493152-25-021421.md) | not reported | [(0.11)](/filings/0001493152-26-022415.md) | [(0.09)](/filings/0001493152-26-035759.md) | [(0.08)](/filings/0001493152-25-021421.md) | not reported | [(0.08)](/filings/0001493152-26-022415.md) | [(0.04)](/filings/0001493152-26-035759.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001493152-24-045009.md) | not reported | [(0.13)](/filings/0001641172-25-009850.md) | [(0.30)](/filings/0001641172-25-023338.md) | [(0.16)](/filings/0001493152-25-021421.md) | not reported | [(0.11)](/filings/0001493152-26-022415.md) | [(0.09)](/filings/0001493152-26-035759.md) | [(0.08)](/filings/0001493152-25-021421.md) | not reported | [(0.08)](/filings/0001493152-26-022415.md) | [(0.04)](/filings/0001493152-26-035759.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.6](/filings/0001493152-23-040604.md) | [4.1](/filings/0001641172-25-005415.md) | [5.4](/filings/0001493152-24-020005.md) | [4.7](/filings/0001493152-24-032141.md) | [3.1](/filings/0001493152-24-045009.md) | [4.3](/filings/0001493152-26-016199.md) | [2.1](/filings/0001641172-25-009850.md) | [3.3](/filings/0001641172-25-023338.md) | [4.0](/filings/0001493152-25-021421.md) | [3.7](/filings/0001493152-26-035759.md) | [4.2](/filings/0001493152-26-022415.md) | [3.9](/filings/0001493152-26-035759.md) |
| Current assets | $m | [2.9](/filings/0001493152-23-040604.md) | [10.1](/filings/0001641172-25-005415.md) | [10.3](/filings/0001493152-24-020005.md) | [11.0](/filings/0001493152-24-032141.md) | [8.8](/filings/0001493152-24-045009.md) | [8.6](/filings/0001493152-26-016199.md) | [7.8](/filings/0001641172-25-009850.md) | [5.8](/filings/0001641172-25-023338.md) | [7.2](/filings/0001493152-25-021421.md) | [7.7](/filings/0001493152-26-035759.md) | [7.7](/filings/0001493152-26-022415.md) | [7.7](/filings/0001493152-26-035759.md) |
| Total assets | $m | [3.2](/filings/0001493152-23-040604.md) | [39.8](/filings/0001641172-25-005415.md) | [39.1](/filings/0001493152-24-020005.md) | [40.5](/filings/0001493152-24-032141.md) | [37.5](/filings/0001493152-24-045009.md) | [35.5](/filings/0001493152-26-016199.md) | [33.9](/filings/0001641172-25-009850.md) | [31.5](/filings/0001641172-25-023338.md) | [32.1](/filings/0001493152-25-021421.md) | [31.8](/filings/0001493152-26-035759.md) | [31.0](/filings/0001493152-26-022415.md) | [30.2](/filings/0001493152-26-035759.md) |
| Current liabilities | $m | [2.0](/filings/0001493152-23-040604.md) | [12.0](/filings/0001641172-25-005415.md) | [10.5](/filings/0001493152-24-020005.md) | [12.1](/filings/0001493152-24-032141.md) | [11.0](/filings/0001493152-24-045009.md) | [11.9](/filings/0001493152-26-016199.md) | [9.9](/filings/0001641172-25-009850.md) | [7.5](/filings/0001641172-25-023338.md) | [8.8](/filings/0001493152-25-021421.md) | [7.5](/filings/0001493152-26-035759.md) | [7.7](/filings/0001493152-26-022415.md) | [7.5](/filings/0001493152-26-035759.md) |
| Total liabilities | $m | [3.0](/filings/0001493152-23-040604.md) | [15.4](/filings/0001641172-25-005415.md) | [14.0](/filings/0001493152-24-020005.md) | [16.6](/filings/0001493152-24-032141.md) | [15.4](/filings/0001493152-24-045009.md) | [14.7](/filings/0001493152-26-016199.md) | [12.6](/filings/0001641172-25-009850.md) | [9.9](/filings/0001641172-25-023338.md) | [11.0](/filings/0001493152-25-021421.md) | [9.5](/filings/0001493152-26-035759.md) | [9.5](/filings/0001493152-26-022415.md) | [9.1](/filings/0001493152-26-035759.md) |
| Shareholders' equity | $m | [(27.1)](/filings/0001493152-24-045009.md) | [1.5](/filings/0001641172-25-005415.md) | [25.1](/filings/0001641172-25-023338.md) | [23.8](/filings/0001493152-25-021421.md) | [22.1](/filings/0001493152-25-021421.md) | [20.8](/filings/0001493152-26-035759.md) | [21.3](/filings/0001493152-26-035759.md) | [21.6](/filings/0001493152-26-035759.md) | [21.2](/filings/0001493152-25-021421.md) | [22.3](/filings/0001493152-26-035759.md) | [21.5](/filings/0001493152-26-035759.md) | [21.1](/filings/0001493152-26-035759.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [217 d](/filings/0001493152-24-045009.md) | [(322) d](/filings/0001641172-25-005415.md) | [(6.6)](/filings/0001641172-25-009850.md) | [(3,068) d](/filings/0001641172-25-023338.md) | [216 d](/filings/0001493152-25-021421.md) | [(549) d](/filings/0001493152-26-016199.md) | [(688)](/filings/0001493152-26-022415.md) | [978 d](/filings/0001493152-26-035759.md) | [(786) d](/filings/0001493152-25-021421.md) | [(1,094) d](/filings/0001493152-26-016199.md) | [(36.7)](/filings/0001493152-26-022415.md) | [(274) d](/filings/0001493152-26-035759.md) |
| Capital expenditure | $k | [225 d](/filings/0001493152-24-045009.md) | [225 d](/filings/0001641172-25-005415.md) | [225](/filings/0001641172-25-009850.md) | [225 d](/filings/0001641172-25-023338.md) | [225 d](/filings/0001493152-25-021421.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.1](/filings/0001493152-23-040604.md) | [13.8](/filings/0001493152-24-020005.md) | [13.8](/filings/0001493152-24-032141.md) | [13.8](/filings/0001493152-24-045009.md) | [25.0](/filings/0001641172-25-009850.md) | [25.8](/filings/0001641172-25-023338.md) | [26.0](/filings/0001493152-25-021421.md) | [28.4](/filings/0001493152-26-022415.md) | [29.5](/filings/0001493152-26-035759.md) | [30.4](/filings/0001493152-25-021421.md) | [33.6](/filings/0001493152-26-022415.md) | [34.2](/filings/0001493152-26-035759.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,425,176 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0001493152-26-035759.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.